NCT02143830 2025-11-12RAFAChildren's Hospital Medical Center, CincinnatiPhase 2 Recruiting70 enrolled
NCT00801489 2025-10-09Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeM.D. Anderson Cancer CenterPhase 2 Recruiting270 enrolled